Cargando…
Exploiting lipotoxicity for the treatment of liver cancer
Metabolic alterations occur frequently in solid tumours, but metabolic cancer therapies are limited by the complexity and plasticity of metabolic networks. We could recently show that activation of the liver X receptor alpha (LXRα) and inhibition of a Raf-1-SCD1 protein complex induces an intracellu...
Autores principales: | Rudalska, Ramona, Zender, Lars, Dauch, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608911/ https://www.ncbi.nlm.nih.gov/pubmed/34302061 http://dx.doi.org/10.1038/s41416-021-01479-7 |
Ejemplares similares
-
COVID-19 and systemic anticancer therapy: exploiting uncertainty
por: Gelderblom, Hans, et al.
Publicado: (2021) -
Exploiting an early immunological window of opportunity in COVID-19
por: Russell, Clark D
Publicado: (2021) -
SCRaMbLEing to understand and exploit structural variation in genomes
por: Steensels, Jan, et al.
Publicado: (2018) -
Babies before bottom lines: A call for Australia to end exploitative marketing of commercial milk formula at home and abroad
por: Munzer, Madeleine, et al.
Publicado: (2022) -
Non-alcoholic fatty liver disease and lipotoxicity
por: Wasilewska, Natalia, et al.
Publicado: (2021)